Practical Considerations for Chargeable Expanded Access: Bridging Global Access Gaps While Driving Biopharma Sustainability

• Evaluate global access disparities, and how chargeable expanded access can advance global reach and patient access
• Navigate country-specific models and feasibility to tailor programs to local rules and economics
• Gain insights into practical application of chargeable expanded access in key markets including implementation challenges, protection of product valuation, and practical lessons learned

Speakers:

Karlijn Doorn

Vice President, Pharma Partnerships & Customer Success

myTomorrows

Stephanie Ferket

Director, Expanded Access Strategy & Customer Success

myTomorrows